Scant Evidence for Proton Pump Inhibitor Role in Gastric Cancer

Previous studies may not have accounted for the confounding role of the diseases for which the medications are prescribed.

Related Keywords

Utah ,United States ,Italy ,Milan ,Lombardia ,American ,Daniele Piovani ,Mark Lewis ,Humanitas University ,American Gastroenterological Association ,Medscape Medical ,Alimentary Pharmacology ,Intermountain Healthcare ,Noncolorectal Gastrointestinal Cancer ,Oncolorectal Gi Cancer ,Gastric Cancer ,Alignant Stomach Neoplasm ,Cancer ,Alignant Neoplasia ,Arcinoma ,Cancer Risk ,Proton Pump Inhibitor ,Cid Suppressive Therapy ,Pi Proton Pump Inhibitor ,Herapy Acid Suppressive ,Peptic Ulcer Disease ,Lcer Peptic ,Meta Analysis ,Stomach ,Tumor ,Bone Density ,Adverse Effects ,Side Effects ,Bones ,C ,